Henderson Jeffrey William 4
4 · HALOZYME THERAPEUTICS, INC. · Filed Apr 1, 2025
Insider Transaction Report
Form 4
Henderson Jeffrey William
Director
Transactions
- Sale
Common Stock
2025-04-01$64.05/sh−503$32,217→ 33,108 total
Footnotes (1)
- [F1]The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on September 17, 2024 in accordance with Rule 10b5-1.